Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1
出版年份 2021 全文链接
标题
Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1
作者
关键词
-
出版物
Advanced Science
Volume -, Issue -, Pages 2002147
出版商
Wiley
发表日期
2021-01-27
DOI
10.1002/advs.202002147
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
- (2020) Bruno Bockorny et al. NATURE MEDICINE
- Enhancing anti-tumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
- (2019) K M Heinhuis et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Autophagy inhibition enhances PD-L1 expression in gastric cancer
- (2019) Xiaojuan Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Sigma-1 receptor ablation impairs autophagosome clearance
- (2019) Huan Yang et al. Autophagy
- A Hypoxia‐Responsive Albumin‐Based Nanosystem for Deep Tumor Penetration and Excellent Therapeutic Efficacy
- (2019) Guangbao Yang et al. ADVANCED MATERIALS
- Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
- (2019) Chin-King Looi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis
- (2019) Quisette P Janssen et al. JNCI-Journal of the National Cancer Institute
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
- (2019) Mara Cirone et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges
- (2019) Feng Yang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Checkpoint inhibitors in pancreatic cancer
- (2019) Andreas Henriksen et al. CANCER TREATMENT REVIEWS
- Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
- (2019) Michael Orth et al. Radiation Oncology
- Irinotecan: 25 years of cancer treatment
- (2019) Christian Bailly PHARMACOLOGICAL RESEARCH
- Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer
- (2018) Huan Meng et al. ADVANCED DRUG DELIVERY REVIEWS
- Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
- (2018) Flavia Radogna et al. BIOCHEMICAL PHARMACOLOGY
- Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
- (2018) Zishuo I. Hu et al. CLINICAL CANCER RESEARCH
- Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
- (2018) Femke M. de Man et al. CLINICAL PHARMACOKINETICS
- PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay
- (2018) Xiaolong Liang et al. Diagnostic Pathology
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- Structural and photodynamic properties of the anti-cancer drug irinotecan in aqueous solutions of different pHs
- (2018) Maria Rosaria di Nunzio et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies
- (2018) Toshiki Iwai et al. Oncotarget
- Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer
- (2018) Sayeda Yasmin-Karim et al. Frontiers in Immunology
- Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
- (2018) Derya Kabacaoglu et al. Frontiers in Immunology
- Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy
- (2018) Sara Musetti et al. ACS Nano
- Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer
- (2018) Xiangsheng Liu et al. ACS Nano
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer
- (2017) Xiangsheng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors
- (2017) Richard A. Skelton et al. JOURNAL OF SURGICAL ONCOLOGY
- The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy
- (2017) Jodi A McKenzie et al. JNCI-Journal of the National Cancer Institute
- PD-L1 Expression in Pancreatic Cancer
- (2017) Lei Zheng JNCI-Journal of the National Cancer Institute
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Effect of lysosomotropic molecules on cellular homeostasis
- (2017) Omer F. Kuzu et al. PHARMACOLOGICAL RESEARCH
- Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis
- (2017) Xiaohui Wang et al. Oncotarget
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy
- (2017) Jodi A McKenzie et al. JNCI-Journal of the National Cancer Institute
- PD-L1 Expression in Pancreatic Cancer
- (2017) Lei Zheng JNCI-Journal of the National Cancer Institute
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Designing nanomedicine for immuno-oncology
- (2017) Wen Jiang et al. Nature Biomedical Engineering
- Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer
- (2016) Xiangsheng Liu et al. ACS Nano
- Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
- (2016) Xiao Zhao et al. BIOMATERIALS
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- Real-time self-tracking of an anticancer small molecule nanodrug based on colorful fluorescence variations
- (2016) Siteng Wang et al. RSC Advances
- Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes
- (2015) Daniel Yuan Qiang Wong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Role of Endoplasmic Reticulum Stress in Human Pathology
- (2015) Scott A. Oakes et al. Annual Review of Pathology-Mechanisms of Disease
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- Immunogenic cell death
- (2015) Abhishek D. Garg et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
- (2015) Ignacio Garrido-Laguna et al. Nature Reviews Clinical Oncology
- ENDOPLASMIC RETICULUM STRESS IN SEPSIS
- (2015) Mohammad Moshahid Khan et al. SHOCK
- Autophagosome–lysosome fusion is independent of V-ATPase-mediated acidification
- (2015) Caroline Mauvezin et al. Nature Communications
- Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
- (2014) M. Aglietta et al. ANNALS OF ONCOLOGY
- ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses
- (2014) Abhishek D. Garg et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
- (2014) E. R. Lutz et al. Cancer Immunology Research
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Two-Wave Nanotherapy To Target the Stroma and Optimize Gemcitabine Delivery To a Human Pancreatic Cancer Model in Mice
- (2013) Huan Meng et al. ACS Nano
- The Role of Autophagic Cell Death and Apoptosis in Irinotecan-treated p53 Null Colon Cancer Cells
- (2013) Stanislav John et al. Anti-Cancer Agents in Medicinal Chemistry
- ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
- (2013) Abhishek D. Garg et al. Autophagy
- Crosstalk between ER stress and immunogenic cell death
- (2013) Oliver Kepp et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Active loading liposomal irinotecan hydrochloride: Preparation, in vitro and in vivo evaluation
- (2013) Hongyan Wei et al. Asian Journal of Pharmaceutical Sciences
- Multifunctional Mesoporous Silica Nanoparticles for Cancer-Targeted and Controlled Drug Delivery
- (2012) Quan Zhang et al. ADVANCED FUNCTIONAL MATERIALS
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Chronic Autophagy Is a Cellular Adaptation to Tumor Acidic pH Microenvironments
- (2012) Jonathan W. Wojtkowiak et al. CANCER RESEARCH
- PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress
- (2012) T Verfaillie et al. CELL DEATH AND DIFFERENTIATION
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
- (2012) Abhishek D Garg et al. EMBO JOURNAL
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer
- (2012) Anastasios Dimou et al. Therapeutic Advances in Medical Oncology
- Endoplasmic Reticulum Stress-induced Apoptosis inLeishmaniathrough Ca2+-dependent and Caspase-independent Mechanism
- (2011) Subhankar Dolai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- Development of an Orthotopic Model of Invasive Pancreatic Cancer in an Immunocompetent Murine Host
- (2010) W. W. Tseng et al. CLINICAL CANCER RESEARCH
- Clinical Significance of B7-H1 and B7-1 Expressions in Pancreatic Carcinoma
- (2010) Liancai Wang et al. WORLD JOURNAL OF SURGERY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
- (2008) J A Burger et al. LEUKEMIA
- In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
- (2008) Paul Tardi et al. LEUKEMIA RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started